DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Theragen Molecular Innovation Private Limited, is an unlisted private company incorporated on 15 December, 2020. It is classified as a private limited company and is located in Kancheepuram, Tamil Nadu. It's authorized share capital is INR 1.00 lac and the total paid-up capital is INR 1.00 lac.
Theragen Molecular Innovation's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by 730.78% over the previous year. At the same time, it's book networth has decreased by 449.58%.
Read more
** All rupee values in INR lacs. Based on March 2022 numbers.
218.43%
-730.78%
-854.28%
-449.58%
None%
148.8%
4.24
-14.58
-13.46
None
-83.4
-13.29
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
Credits Balance : 0
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Confirm unlock request
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2021 | Mar 2022 | |
|---|---|---|
| Sales | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO |
| Networth | ||
| Borrowings | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | |
|---|---|---|
| Equity Capital | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | |
|---|---|---|
| Sales + | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | |
|---|---|---|
| Solvency + | ||
| Total Debt/Equity | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO |
| Liquidity + | ||
| Current Ratio | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO |
| Performance | ||
| Gross Margin | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO |
| Return + | ||
| Return on Equity | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO |
| Efficiency + | ||
| Days Payable | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO |
| Working Capital | ||
| Cash Conversion Cycle | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Arumugam Sivaraman | 00616208 | 4 years |
| Director | Arumugam Andal | 00633601 | 4 years |
| Director | Chaniyilparampu Nanappan Ramchand | 05166709 | 4 years |
The incorporation date of THERAGEN MOLECULAR INNOVATION PRIVATE LIMITED is 15 December, 2020
The authorized share capital of THERAGEN MOLECULAR INNOVATION PRIVATE LIMITED is INR ₹ 1.0 L.
The paid-up capital of THERAGEN MOLECULAR INNOVATION PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of THERAGEN MOLECULAR INNOVATION PRIVATE LIMITED is No.153, 1st Main Road, Industrial Estate Perungudi Chennai Kancheepuram Tamil Nadu - 600096
The CIN number of THERAGEN MOLECULAR INNOVATION PRIVATE LIMITED is U73100TN2020PTC140124.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
